Donn Young is the former director of the Ohio State University Comprehensive Cancer Center Biostatistics Unit where he spent ...

Developing tests that better identify patients at risk of dying from prostate cancer can decrease overtreatment. In the ...

The aggressiveness of a cancer is based on several factors, including the tumor's grade and stage, and the cells' genetic ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Former US president Joe Biden, 82, has been diagnosed with an “aggressive form” of prostate cancer, and it has spread to his ...

A Gleason score of 8–10 indicates a highly aggressive prostate cancer that will likely grow quickly. In Australia, 67.9% of ...

"It went over my head. I wasn't listening, but Pamela was. When we got back, she asked if I even knew what had been said." ...

When Alun Griffiths, 71, signed up to Swansea City AFC Foundation and Prostate Cymru’s cancer testing event in April 2024, he ...

A newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish men and may increase sensitivity to ...

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients ...